The mithramycin biosynthesis gene cluster of Streptomyces argillaceus ATCC 12956 contains 34 ORFs and includes two putative regulatory genes (mtmR and mtrY), which encode proteins of the SARP (Streptomyces antibiotic regulatory protein) and PadR transcriptional regulator families, respectively. MtmR was proposed to behave as a positive regulator of mithramycin biosynthesis. Inactivation and overexpression of mtrY indicated that it is also a positive regulator of mithramycin biosynthesis, being non-essential but required to maintain high levels of mithramycin production in the producer strain. Transcriptional analyses by reverse transcription PCR and quantitative realtime PCR of mithramycin genes, and promoter-probe assays in S. argillaceus polyketide synthase and regulatory mutants and the WT strain, and in the heterologous host Streptomyces albus, were carried out to analyse the role of MtmR and MtrY in the regulation of the mithramycin gene cluster. These experiments revealed that MtmR had a positive role, activating expression of at least six polycistronic units (mtmR-mtmE, mtmQ-mtmTII, mtmX-mtmY, mtmV-mtmTIII, mtmW-mtmMI and mtmGI-mtrB) and one monocistronic unit (mtmGII) in the mithramycin gene cluster. However, MtrY played a dual role in the mithramycin gene cluster: (i) repressing the expression of resistance genes and its coding gene itself by controlling the activity of the mtrYp promoter that directs expression of the regulator mtrY and resistance genes, with this repression being released in the presence of mithramycin; and (ii) enhancing the expression of mithramycin biosynthesis genes when mithramycin is present, by interacting with the mtmRp promoter that controls expression of the mtmR regulator, amongst others.
INTRODUCTION
Streptomyces is a genus of Gram-positive bacteria belonging to the phylum Actinobacteria, which is characterized by a cycle of morphological differentiation and is an important source of bioactive compounds, such as antibiotics, antitumour compounds and immunosuppressant agents, amongst others (Bérdy, 2012; Chater, 1993; Flärdh & Buttner, 2009; Newman & Cragg, 2012) . In general, biosynthesis of these compounds takes place in parallel with the development of aerial mycelium in surface-grown cultures or at the end of the exponential growth phase in submerged cultures, when starvation and other environmental factors appear (Bibb, 2005; Liu et al., 2013; Martín et al., 2011; Méndez et al., 1985; van Wezel & McDowall, 2011) . Therefore, biosynthesis genes of bioactive compounds are not usually expressed throughout the entire life cycle, but rather are under the control of a complex network of regulatory elements (Bibb, 2005; Cundliffe, 2006; Liu et al., 2013; Martín & Liras, 2010; van Wezel & McDowall, 2011) . This regulation is exerted at different levels and usually involves one or more clustersituated regulators (CSRs; Huang et al., 2005) , which are normally considered as 'low-level' or pathway-specific regulators, although it has been found that some of them can control 'high-level' regulators and also the expression of other biosynthesis pathways (Huang et al., 2005; Rodríguez et al., 2008) . Pathway-specific regulation can involve a single regulator, as in the case of the actinorhodin and streptomycin biosynthesis pathways (Fernández-Moreno et al., 1991; Retzlaff & Distler, 1995) ; in other cases, several pathway-specific regulators are involved, such as in the daunorubicin and tylosin biosynthesis pathways Abbreviations: CSR, cluster-situated regulator; DW, dry weight; qRT, quantitative real-time; RLU, relative luminescence units; RT, reverse transcription; SARP, Streptomyces antibiotic regulatory protein. (Cundliffe, 2008; Otten et al., 2000) . Understanding the regulation of antibiotic biosynthesis pathways can help to engineer pathways in order to generate specific compounds or to increase the production of target compounds. In this sense, engineering both 'low-level' and 'high-level' regulatory proteins has been used in order to increase the productivity of antibiotics in otherwise low-producer WT strains (Olano et al., 2008) .
Mithramycin is a member of the aureolic acid group that was approved for use as an anticancer drug in 1970 (Newman & Cragg, 2012) . The mithramycin gene cluster of Streptomyces argillaceus has been cloned and characterized (Lombó et al., 2006) . In addition, using combinatorial biosynthesis strategies, several new derivatives have been generated, some of which showed higher antitumour activity and/or less toxicity than the parental compound (Albertini et al., 2006; García et al., 2011; Nú ñez et al., 2012; Pérez et al., 2008; Remsing et al., 2003) . Moreover, in recent years new uses and activities have been described for mithramycin, such as inhibition of apoptosis or antiangiogenic activity, which has renewed interest in this drug (Chatterjee et al., 2001; Jia et al., 2007 Jia et al., , 2010 , and in enhancing the production yields of mithramycin and its derivatives. Recently, several metabolic engineering strategies have been successfully applied to increase the production of mithramycin and derivatives (Zabala et al., 2013) . A complementary approach could be to manipulate regulatory genes involved in its biosynthesis, which will require an understanding of the regulation of mithramycin biosynthesis. The mithramycin gene cluster contains two CSRs, mtmR and mtrY, which have been proposed to be involved in the regulation of mithramycin biosynthesis (Garcia-Bernardo et al., 2000; Lombó et al., 1999) . mtmR codes for a SARP (Streptomyces antibiotic regulatory protein)-like regulator that is essential for mithramycin biosynthesis (Lombó et al., 1999) . Previous information on mtrY did not show any similarity to known regulatory proteins, but indicated the existence of a putative helixturn-helix motif that suggested its possible regulatory role (Garcia-Bernardo et al., 2000) . In this paper, we addressed the study of the transcriptional regulation of mithramycin biosynthesis by studying the expression pattern of the mithramycin genes in the WT in comparison with mutants in specific regulatory genes, and by analysing the effect of these regulatory elements on the activity of their promoters, in the presence and absence of mithramycin.
METHODS
Bacterial strains and culture conditions. Streptomyces argillaceus ATCC12596, a mithramycin producer, was used as the donor of chromosomal DNA, and for gene replacement and expression experiments. S. argillaceus M13R1 is a mtmR-minus mutant (Lombó et al., 1999) and S. argillaceus DPK is a mithramycin non-producer mutant with a deletion in the polyketide synthase genes (Lombó et al., 1996) . Streptomyces albus J1074 (Kieser et al., 2000) was used as the host for promoter-probe assays. For mithramycin production and luciferase tests, an overnight culture of the corresponding strain in tryptic soy broth medium was used as a seed culture to inoculate three 250 ml flasks containing 50 ml R5A liquid medium (Fernández et al., 1998) , until OD 600 0.2 was achieved. Cultures were then incubated at 30 uC and 250 r.p.m. for several days. Escherichia coli ET12567/pUB307 (Kieser et al., 2000) ).
DNA manipulation and plasmids. DNA manipulation was performed according to standard procedures for E. coli (Sambrook et al., 1989) and for Streptomyces (Kieser et al., 2000) . Platinum Pfx DNA polymerase (Invitrogen) and 2.5 % DMSO were used for all PCR amplifications. Purified amplicons were sequenced to confirm their identities. pBSKT (Lombó et al., 1999) was used for gene replacement. pIAGO (Aguirrezabalaga et al., 2000) is a bifunctional and multicopy plasmid, and was used for gene expression experiments. pLUXAR+ (Rodríguez-García et al., 2007) is an integrative promoter-probe vector. pUK21 (Vieira & Messing, 1991) was used for subcloning. pFL3R1 and pFL3R (Lombó et al., 1999) , and pJG144 (Garcia-Bernardo et al., 2000) are pIAGO derivatives containing mtmR and mtrY genes, respectively, and were used for complementation and/or expression experiments.
Plasmid constructs. Several plasmid constructs were made in order to assay the promoter activity located upstream of the mtmR, mtrX and mtrY genes. DNA regions were amplified by PCR using oligonucleotides listed in Table S1 (available in the online Supplementary Material) and cloned into the BamHI, EcoRI or NdeI sites of the promoter-probe plasmid pLUXAR+, generating pR, pX and pY, respectively. To assay these promoter activities in S. argillaceus mutant strains, a hygromycin resistance cassette was subcloned as a 1.7 kb NheI/SpeI fragment from pLHyg (Olano et al., 2004) into the unique XbaI site of pLUXAR+, pR and pY, divergently from luxAB genes, generating pLUX-H, pR-H and pY-H respectively.
To test the effect of regulatory proteins on mtmRp and mtrYp promoters, several plasmids were constructed as follows. To generate pLUX-E, pR-E and pY-E, the ermEp promoter was first subcloned as a 300 bp EcoRI/BamHI fragment from pIAGO into the EcoRI/BamHI unique sites of pUK21, generating pUK21-E, and then it was rescued as a SpeI fragment and subcloned into the XbaI site of pLUXAR+, pR and pY, respectively (see Fig. 5 ). pR-R, pY-R, pR-Y and pY-Y were generated by PCR amplifying mtmR and mtrY genes using the primers listed in Table S1 , and cloned under the control of the erythromycin resistance promoter (ermEp) in the XbaI site of pUK21-E. Then, each gene plus ermEp was rescued as a SpeI fragment and cloned into the XbaI site of pR and pY, divergently from luxAB genes, generating the different plasmid constructs shown in Fig. 5 .
Generation of mutant S. argillaceus DY. For the generation of this mutant, plasmid pABF2 was constructed as follows. A BglII DNA fragment (7.5 kb) containing mtmOIV, mtrX, mtrY, mtrA, mtrB and the 39 end of mtmGI was cloned into the BamHI site of pBSKT. Then, an apramycin resistance cassette was subcloned as a PstI fragment from pEFBA (Lozano et al., 2000) into the NsiI site located in the mtrY gene, in the same direction of transcription. This construct (pABF2) was used to transform S. argillaceus protoplasts. Transformants were selected with apramycin and were tested for their susceptibility to thiostrepton to select mutant strains.
Gene expression analysis. Total RNA was obtained from S. argillaceus WT and S. argillaceus mutants M13R1 and DY. Samples (20 ml) were harvested from cultures of these strains after growth for 48 h (i.e. during mithramycin production; see Fig. 1 ), were mixed with 30 ml RNA Protect Bacteria Reagent (Qiagen) and maintained at IP: 54.70.40.11
On: Sat, 03 Aug 2019 21:17:52 room temperature for 5 min. Mycelia were then harvested by centrifugation and stored at 220 uC until use. Total RNA was isolated from frozen pellets using a standard lysis method (Kieser et al., 2000) and purified using a RNeasy Midi kit (Qiagen) according to the manufacturer's instructions. Isolated RNA was subjected to an additional DNase I treatment (TURBO DNA-free; Ambion) to eliminate DNA contamination. This RNA was used as template for gene expression analysis by reverse transcription (RT)-PCR.
Qualitative gene expression was studied using the SuperScript One-Step RT-PCR system with Platinum Taq DNA polymerase (Invitrogen). cDNA synthesis was performed using 20-150 ng total RNA as template (depending of the primer pairs) at 50 uC for 30 min, followed by heating at 94 uC for 2 min. Sample mixtures included 32.2 U RNAguard RNase inhibitor (Amersham Biosciences). Amplification conditions were: 33 cycles at 95 uC for 1 min; 45-60 uC (depending of primers) for 1 min; 72 uC for 1 min; and a final extension step at 72 uC for 10 min. Oligonucleotides (Table S1) were designed within structural, resistance and regulatory genes of the mithramycin biosynthesis gene cluster to amplify, amongst others, those genes located at the beginning and at the end of putative transcriptional units. The upstream primer for mtmH was located just outside its coding sequence within mtmA, in order to avoid amplification of another copy of mtmH, which is located in another part of the chromosome. Primers for mtrY were located downstream of the NsiI site, downstream of the insertion site of the apramycin resistance cassette in the S. argillaceus DY mutant. Primers were designed to produce cDNAs of~400-600 bp and the identity of these was verified by direct sequencing. Negative controls for each pair of primers were carried out with Platinum Taq DNA polymerase (Invitrogen) in the absence of reverse transcriptase. To elucidate the transcriptional organization at the 59 and 39 ends of the mithramycin biosynthesis gene cluster, primers were designed to amplify some intergenic regions (Table S1 ). hrdB gene expression levels were used to normalize RNA concentration of the tested strains, as described previously (Rodríguez et al., 2008) . The RT-PCR products were resolved by 1.4 % agarose gel electrophoresis, stained with ethidium bromide and visualized using a Gel Doc system (Bio-Rad).
Quantitative real-time (qRT)-PCR was used to quantify gene expression of selected genes. A total amount of 0.5 mg RNA was used to synthesize cDNA using an iScript cDNA synthesis kit (Bio-Rad). qRT-PCRs were carried out on an ABI PRISM 7500 (Applied Biosystems), with SYBR Green PCR Master Mix (Applied Biosystems). Triplicate PCRs were carried out for each sample analysed and three independent experiments were performed. hrdB was used as a housekeeping gene in each sample in order to standardize the results by eliminating variation in RNA and cDNA quantity and quality. Absence of chromosomal DNA contamination was checked by qRT-PCR. Primers (Table S1 ) were designed using the algorithms provided by Primer Express software 2.0 (Applied Biosystems) and their efficiency was calculated based on the slope of a standard curve. To determine amplification specificity, an additional dissociation curve analysis was performed after the last cycle, showing one single peak in all cases. PCR results were given as the increase in the fluorescence signal of the reporter dye detected and visualized by the 7500 System SDS software version 1.4 (Applied Biosystems). Changes in gene expression are represented with respect to the control sample (WT strain).
Luciferase assay, mithramycin production and growth determination. The luciferase activity coded by luxAB was measured in a Luminoskan luminometer (Labsystems) as described previously (Rodríguez-García et al., 2007; Santos-Beneit et al., 2008) . Cell samples from 1 ml R5A cultures were frozen until use for luminescence assays [in relative luminescence units (RLU)]. Mithramycin production was determined by HPLC using a mBondapak C 18 column (Waters). Samples (0.5 ml) from cultures of the different strains were extracted with ethylacetate supplemented with 5 % formic acid. Mithramycin concentrations were estimated by measuring peak areas and comparing them with known concentrations of mithramycin. In parallel, samples (1 ml) were harvested for growth determination (as DNA concentration) by the colorimetric diphenylamine method of Burton (1956) . For dry weight (DW) determination, samples were washed twice with Milli-Q water, dried for 4 days at 80 uC and then weighed. Measurements were always obtained from three independent cultures.
RESULTS

Role of mtmR and mtrY in mithramycin production
Two putative regulatory genes have been identified in the mithramycin gene cluster: mtmR, which encodes a SARPtype activator protein (Wietzorrek & Bibb, 1997 ) that was previously proposed to be an activator of mithramycin biosynthesis (Lombó et al., 1999) , and mtrY, which is 40 kb away from mtmR and codes for a putative regulatory protein (Garcia-Bernardo et al., 2000) . Comparisons of MtrY with proteins in databases showed similarities with several PadR-like proteins of unknown function from different actinomycetes, such as GenBank accession number AFO53534 from Streptomyces sp. WAC1438 (59 % identical amino acids), GenBank accession number WP_018681227 from Actinokineospora enzanensis (62 %) or GenBank accession number WP_020644137 from Amycolatopsis balhimycina (59 %). In order to confirm the role of mtrY in mithramycin biosynthesis, a novel null mutant strain (S. argillaceus DY) was generated by inserting the apramycin resistance cassette aac(3)IV in mtrY, in the same direction of transcription to avoid a possible polar effect on downstream genes. PCR and Southern blot analysis were performed to confirm the replacement of the WT copy of mtrY by the mutated version (Fig. S1 ). Mithramycin production of S. argillaceus DY was monitored in liquid cultures, and was compared with S. argillaceus M13R1 (mtmR null mutant) and with the WT strain (Fig. 1a) . The maximum level of mithramycin production in the WT strain was reached after 120 h, at the stationary phase. Neither mithramycin nor any biosynthesis intermediates were detected in cultures of M13R1, whilst mutant DY produced mithramycin, although production levels were~70 % lower than in the parental strain. Mithramycin production was recovered/increased in S. argillaceus M13R1 and DY expressing WT copies of mtmR and mtrY, respectively, indicating that genes located downstream of the targeted regulatory genes were expressed in the mutant strains (Fig. S2 ). In addition, expression of any of these genes in the WT strain had a positive effect on mithramycin production: mtmR (pFL3R) led to a high increase in mithramycin production throughout the growth period tested, with final yields~155 % higher, whilst in the case of S. argillaceus expressing mtrY (pJG144), mithramycin production was slightly higher than in the control strain (final yields~13 % higher) (Fig. 1b) . These results were in agreement with previous data obtained under other cultivation conditions (Garcia-Bernardo et al., 2000; Lombó et al., 1999) . All these results suggested that both mtmR and mtrY coded for positive transcriptional regulators of mithramycin biosynthesis, mtmR but not mtrY being essential for mithramycin production, and the latter being required to maintain high levels of mithramycin production.
Transcriptional regulation of the mithramycin gene cluster
To investigate the role of mtmR and mtrY in the transcriptional regulation of mtm genes, gene expression analysis of selected mtm genes was evaluated by RT-PCR. Total RNA was isolated from cultures grown for 48 h (corresponding to the beginning of the production stage in the WT strain) from S. argillaceus WT and mutant strains S. argillaceus DY (mtrY-minus) and S. argillaceus M13R1 (mtmR-minus). As shown in Fig. 2 , all genes were expressed in the WT strain, including regulatory (mtmR and mtrY), resistance (mtrX, mtrA and mtrB) and structural genes. On the contrary, transcription was absent for most of the genes in the mtmR-minus mutant, with the sole exception of two sets of genes located at the ends of the mtm gene cluster, which were transcribed, but at a significantly lower level of expression than in the WT strain: mtmA-mtmD (at the left end of the cluster) and mtrX-mtrB (at the right end of the cluster). Mutant M13R1 contains an apramycin resistance cassette that replaced mtmR and its upstream promoter region, and the upstream region of mtmZ. This resistance cassette had its own promoter and lacked a transcriptional terminator. Therefore, transcription of genes located downstream of the apramycin resistance cassette could be directed by the apramycin resistance promoter. This would imply that this group of genes is transcribed as a polycistronic transcriptional unit from mtmR to mtmE. To confirm this fact, the possible co-transcription of these genes in the WT strain was analysed. Primers were designed to synthesize cDNAs from the different intergenic regions (Table S1 ). As shown in Fig. 3(a) , transcripts between upstream and downstream genes were detected in all the cases, confirming that mtmR-mtmE could be co-transcribed as a polycistronic unit. However, transcription of genes located at the right end of the cluster (mtrY-mtrB) in the mtmR-minus mutant could be explained if transcription of these genes was partially MtmR-independent (see below).
In the case of the mtrY-minus mutant, transcription of most genes was lower than in the WT strain, including mtmR and those genes involved in polyketide and sugar biosynthesis. Exceptions were mtrX-mtrB genes, which were apparently transcribed at the same or even higher levels in the mtrY-minus mutant than in the WT strain. The mtrY-minus mutant was generated by inserting the apramycin resistance cassette in mtrY and therefore some transcription of genes downstream of this cassette could be driven by the apramycin resistance promoter.
These results were consistent with the idea that MtmR was the main and essential activator of the mithramycin gene cluster, and that MtrY was a positive regulator of mtmR. Moreover, these results indicated that transcription of mtrX-mtrB could be differentially regulated from the rest of the genes and suggested the existence of additional promoters within this region that could be MtmRindependent.
Transcriptional organization of the right end of the cluster At the right end of the mtm gene cluster there is a set of genes transcribed in the same direction (mtmGI-mtrB) that could constitute a polycistronic unit. However, results described above suggested that some of these genes (mtrXmtrB) were differentially expressed. In order to further investigate the transcriptional organization of this region we decided to analyse expression of intergenic regions from mtmGI to mtrB by RT-PCR, in the WT and in the regulatory mutant strains (Fig. 3b) . Expression was detected for all intergenic regions both in the WT strain and in the DY mutant, although the amount of transcripts was significantly different in both strains: whilst in the DY mutant the transcript levels for the mtmOIV-mtrX intergenic region were lower, those corresponding to intergenic regions mtrX-mtrY, mtrY-mtrA and mtrAmtrB were equal or even higher. Moreover, in the mtmRminus mutant (M13R1), transcripts corresponding to intergenic regions mtmGI-mtmOIV and mtmOIV-mtrX were not detected and those for other intergenic regions were detected, but at a lower level.
To further support these results, qRT-PCR analysis was carried out (Fig. 3c) . RNA from the WT strain was used as a calibration sample. Analysis of transcripts from the DY mutant confirmed that expression levels of mtmGI and mtmOIV were lower in the mutant in relation to the WT strain; however, on the contrary, expression levels of mtrX, mtrY, mtrA and mtrB were higher, with mtrA and mtrB showing the highest expression levels. Although some expression from mtrY to mtrB could be attributed to the inserted apramycin resistance cassette within mtrY in this mutant, this could not explain the amount of transcripts corresponding to mtrX. However, expression of mtmGI and mtmOIV was not detected in the M13R1 mutant, whilst mtrX, mtrY, mtrA, and mtrB genes were poorly expressed and clearly at a much lower level than in the WT strain, with the amount of the mtrX transcript being the lowest. All these results indicated that in the WT strain mtmGI-mtrB were co-transcribed from a promoter located upstream of mtmGI that was MtmR-dependent; however, in the absence of MtmR, mtrX-mtrB could be cotranscribed from other promoter regions.
In order to confirm the existence of additional promoter regions, DNA regions upstream of mtrX and mtrY were amplified by PCR and were subcloned into the promoterprobe vector pLUXAR+ upstream of reporter genes luxAB, generating pX (mtrXp) and pY (mtrYp). These plasmids were introduced into the S. albus J1074 strain, and the activities of promoters were measured by the luciferase assay and using S. albus containing the empty vector pLUXAR+ as control (Table 1) . The luciferase activities observed with pX and pY compared with the control confirmed the existence of promoter regions in these DNA fragments, but with important differences in promoter strength: whilst pY showed a luciferase activity~99-fold higher than the control at 24 h, the activity of pX was much lower (~13-fold higher than the control). In all cases, the maximum promoter activity was achieved after 24 h and then gradually decreased (data not shown). These results indicated that in the absence of MtmR, mtrYp was the main promoter activity controlling expression of mtrY-mtrB and that mtrXp could be Fig. 2 . Gene organization and gene expression analysis of the mithramycin biosynthesis gene cluster (mtm). Not drawn to scale. Genes are represented by black (regulatory), dark grey (structural), light grey (resistance) and white (unassigned function) arrows. RNA was extracted from mycelia of S. argillaceus WT and the regulatory null mutants M13R1 (mtmR-minus) and DY 
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Regulation of mtmRp and mtrYp promoters by MtmR and MtrY
The results described above showed that expression of mtm genes was MtmR-dependent, with the exception of resistance genes that could be expressed in its absence, but at a much lower extent. In addition, they indicated that MtrY positively affected expression of mtmR, thus favouring expression of all MtmR-dependent genes. Also, these results suggested that MtrY would act as a repressor of resistance genes and of its coding gene. To further clarify the role of regulatory proteins MtmR and MtrY, it was decided to assay promoter activities of mtmRp (promoter located upstream of mtmR) and mtrYp in the presence and absence of MtmR and MtrY. First, promoter activities of mtmRp (pR-H) and mtrYp (pY-H) were tested in S. argillaceus strains either blocked in mtmR (S. argillaceus M13R1) or in mtrY (S. argillaceus DY).
As shown in Fig. 4 , both promoters showed the highest activity between 12 and 24 h of incubation, and then their activities gradually decreased. In the case of mtrYp, the activity increased again after 72 h. This pattern was not observed when this promoter was tested in the S. albus J1074 strain (data not shown), which suggested the existence of additional factors in S. argillaceus, such as regulatory proteins or metabolites (i.e. mithramycin and/or biosynthesis intermediates) that could modulate mtrYp expression. As can be observed in Fig. 4(a) , the lack of MtmR caused a decrease in the activity of mtmRp, which was much more noticeable at later incubation times, and also of mtrYp (Fig. 4b) . However, the absence of MtrY caused a consistent increase in promoter activity of mtrYp, being~24-and 22-fold higher at 24 and 72 h, respectively (Fig. 4b) . In the absence of MtrY, the mtmRp activity increased at 12 and 24 h of incubation, and then showed a sharp decrease in activity at later incubation times. These results suggested that mtrYp and mtmRp were positively regulated by MtmR, and negatively regulated by MtrY, although this negative effect on mtmRp was dependent on the incubation time. The positive role of MtmR on mtrYp activity suggested by these experiments was apparently in contradiction to the fact that mtrY was expressed from mtrYp in the mtmR-minus mutant. To try to clarify this, mtrYp activity was also assayed in a mutant containing mtmR and mtrY, but blocked at the earliest step of mithramycin biosynthesis (S. argillaceus DPK). mtrYp showed a decrease in promoter activity in this mutant strain compared with the WT strain, suggesting that it is the absence of mithramycin that affects mtrYp activity rather than the presence/absence of MtmR.
To clarify these results, lessening the influence of the S. argillaceus background and of mithramycin (and biosynthesis intermediates), we tested the effect of each regulatory protein on promoter activities in S. albus. The mtmRp and mtrYp promoters were cloned upstream of the lux operon in a pLUXAR derivative (pLUX-E), in which the erythromycin resistance promoter (ermEp) was cloned divergently from the lux operon (Fig. 5) . To test the effect of MtmR and MtrY on the activity of these promoters, their coding genes were independently cloned downstream of ermEp, generating the constructs shown in Fig. 5 . These plasmid constructs were introduced into S. albus, and the effect of the MtmR and MtrY proteins on promoter regions was evaluated by measuring luciferase activity over time (Fig. 6a) . Comparisons of luciferase activities driven by mtmRp in the absence of regulatory proteins (pR-E) with those obtained in the presence of either mtmR (pR-R) or mtrY (pR-Y) genes confirmed that this promoter was positively regulated by MtmR and that MtrY caused some repression, which was more noticeable at earlier incubation times (31 and 26 % lower luciferase activities at 24 and 48 h, respectively). On the contrary, comparison of the promoter activity of mtrYp in the absence of regulatory proteins (pY-E) and in the presence of mtrY (pY-Y) also showed that MtrY exerted some repressor effect on its own promoter, which was very obvious at 24 h of incubation Fig. 4 . Promoter activities of (a) mtmRp and (b) mtrYp in S. argillaceus WT, and mutant strains M13R1 (mtmR-minus), DY (mtrY-minus) and DPK (mithramycin non-producer mutant). Cultures were grown in R5A supplemented with hygromycin, and samples were taken at 0, 12, 24, 48 and 72 h post-incubation for luciferase assays. Results represent the mean±SD of three independent experiments. pR-H and pY-H are pLUX-H derivatives with mtmRp and mtrYp cloned upstream of the lux operon, respectively.
(50 % less luciferase activity). However, the presence of mtmR (pY-R) did not increase the activity of mtrYp. This result was in accordance with those results shown in Figs 2 and 3 that indicated that mrtYp activity was MtmRindependent and supports the assertion outlined above.
Results described above demonstrated the positive regulatory role of MtmR on its own promoter mtmRp, but not on mtrYp, and suggested that MtrY acts as a repressor of mtrYp and mtmRp. This result contradicts the initial data both at the production and transcriptional level in S. argillaceus that indicated that MtrY acts as an activator of mithramycin biosynthesis. In concordance with the results shown above, we considered that some of the differences observed could be caused by the absence of mithramycin in cultures of S. albus. To test the influence of mithramycin on promoter activities, we incubated S. albus strains in R5A medium supplemented with 1 mg mithramycin ml 21 (a concentration below the MIC of mithramycin for S. albus) and evaluated the activity of promoters by measuring luciferase activity (Fig. 6b) . When mithramycin was added to the cultures, MtrY did not repress mtmRp, but rather increased its activity (49 and 53 % higher luciferase activities at 24 and 48 h, respectively; see pR-Y versus pR-E in Fig. 6b ). Under these conditions, MtrY also did not repress mtrYp after 24 h of incubation. The positive effect of MtrY in the presence of mithramycin on mtrYp was not so obvious, only being clearly detected in cultures at 24 h of incubation. This and the above-mentioned results would explain the apparent inconsistency of why mtrYp activity was lower in the mtmR-minus and DPK mutants (Fig. 4b) : production of mithramycin is blocked in . Plasmid constructs used in this work to test the effect of expressing mtmR and mtrY on mtrYp and mtmRp promoter activities. luxA and luxB code for the components of luciferase; luxC codes for the enzyme acyl-reductase; mmr, mmrt-1 and mmrt-2, terminator sites; mtmRp, promoter region upstream of mtmR; mtrYp, promoter region upstream of mtrY; ermEp, erythromycin resistance promoter. The length of the different plasmids is shown in parentheses.
both mutants, but mtrY is expressed. Therefore, in the absence of mithramycin, MtrY negatively affects the activity of mtrYp (Fig. 6a) .
DISCUSSION
In this study we carried out a transcriptional analysis of the mithramycin gene cluster in S. argillaceus and analysed the role of two CSRs in the regulation of the cluster. The biosynthesis gene cluster of antitumour mithramycin in S. argillaceus comprises 34 ORFs, which are organized in at least seven transcriptional units. It includes two CSRs (mtmR and mtrY) that are located at each end of the cluster (Garcia-Bernardo et al., 2000; Lombó et al., 1999) . MtmR is highly similar to transcriptional activators of the SARP family that are involved in the biosynthesis of different antibiotics. Members of this family have been shown to activate the transcription of biosynthesis genes by binding to operator regions located at target promoters (Arias et al., 1999; Sheldon et al., 2002) . Similar to other SARPs, MtmR is also a positive regulator that is essential for mithramycin biosynthesis. Transcriptional analysis of the mtmR-minus mutant in comparison with the WT strain supports the existence of four polycistronic units (mtmQ-mtmTII, mtmX-mtmY, mtmV-mtmTIII and mtmW-mtmMI) and one monocistronic unit (mtmGII) that are positively regulated by MtmR, as no transcription of these genes was detected in the mtmR-minus mutant. MtmR also regulates transcription of a polycistronic unit (mtmGImtrB) from a promoter located upstream of mtmGI, although some transcription of mtrX-mtrB still occurs in the absence of MtmR. This could be explained by the existence of additional promoters within this region (mainly mtrYp). Moreover, we propose that MtmR also regulates expression of a polycistronic unit (mtmR-mtmD) by acting on the mtmRp promoter. Although transcripts from this region are still detected in the mtmR-minus mutant, we have demonstrated by promoter-probe assays that the activity of the mtmRp promoter was lower in the absence of mtmR (S. argillaceus DR pR-H versus S. argillaceus WT pR-H; Fig. 4a ) and that this activity is enhanced by its presence (S. albus pR-R versus S. albus pR-E; Fig. 6a ). The detected residual transcription in this region could be explained by the promoter of the apramycin resistance cassette replacing the mtmR gene in this mutant, which directs transcription of downstream genes.
Regulation of the mithramycin gene cluster is also under the control of the second CSR, mtrY, which codes for a protein similar to PadR-like proteins of unknown function identified in different actinomycetes strains. This is a quite recently identified family of regulatory proteins, named after the phenolic acid decarboxylation repressor of Bacillus subtilis, Pediococcus pentosaceus and Lactobacillus plantarum (Barthelmebs et al., 2000; Gury et al., 2004; Tran et al., 2008) . To date, only a few members of this family have been characterized and these were shown to regulate diverse processes, including multidrug resistance, virulence, circadian rhythms and detoxification (Agustiandari et al., 2011; Barthelmebs et al., 2000; Gury et al., 2004; Huillet et al., 2006; Kovacikova et al., 2003) . None of these characterized regulators belong to the actinomycetes group nor are they involved in antibiotic biosynthesis. This family of proteins typically possesses a conserved N-terminal winged helix-turn-helix DNA-binding domain and a variable C-terminal helical domain involved in dimerization (Arita et al., 2007; De Silva et al., 2005; Fibriansah et al., 2012; Madoori et al., 2009) . In LmrR, a flat-shaped hydrophobic pore at the dimer centre serves as a multidrug-binding site, existing in an allosteric coupling between the multidrug-and DNA-binding sites, which is proposed to be involved in the induction mechanism (Madoori et al., 2009 of mithramycin. In accordance with this, transcription analysis of mtrY and resistance genes comparing the mtrYminus mutant with the WT strain showed that all these genes were expressed at a higher level in the former than in the latter. We propose that MtrY could play this repressor role by mainly regulating mtrYp promoter activity. Accordingly, promoter-probe assays of mtrYp carried out in S. argillaceus indicated that the activity of this promoter was higher in the absence of MtrY (S. argillaceus DY pY-H versus S. argillaceus WT pY-H; Fig. 4b ). In addition, promoter-probe assays of mtrYp using S. albus as host in the presence or absence of MtrY showed that expression of mtrY has a negative effect on mtrYp activity (S. albus pY-Y versus S. albus pY-E; Fig. 6a ), reinforcing the role of MtrY as a repressor of its own promoter and consequently of genes expressed under its control. Moreover, we showed that mithramycin plays an important role in this regulation, as this repressor effect of MtrY was not observed in a mithramycin non-producer mutant (S. argillaceus DPK) or when mithramycin was added to cultures (S. albus pY-Y versus S. albus pY-E; Fig. 6b ), which suggests that mithramycin could interact with MtrY by attenuating its putative binding activity to target DNA and thereby modulating mtrYp activity. Some characterized PadR-like proteins play similar roles in the expression of resistance genes. Such is the case of LadR and LmrR that negatively regulate expression of multidrug efflux pumps in Listeria monocytogenes and Lactococcus lactis, respectively; this repression being released upon their interaction with some drugs (Agustiandari et al., 2011; Huillet et al., 2006) . In Streptomyces, there are examples of repressors that inhibit expression of antibiotic resistance and export in antibiotic biosynthesis pathways; this repression being diminished by the antibiotic itself and/or some biosynthesis intermediates. Such is the case of TetR-like repressors ActR and SimR from the actinorhodin and simocyclinone gene clusters, respectively (Le et al., 2009; Tahlan et al., 2007; Xu et al., 2012) . However, as far as we know this is the first example showing that a PadR-like regulator acts as a repressor of expression of resistance genes in antibiotic gene clusters in Streptomyces.
MtrY also plays a positive regulatory role in mithramycin biosynthesis, as mutants affected in this gene produced lower amounts of mithramycin and its overexpression in the WT strain enhanced mithramycin production. In addition, transcriptional analysis of the mtrY-minus mutant in comparison with the WT strain supports this assertion as all biosynthesis genes were clearly less transcribed in the mutant than in the WT strain, the activator mtmR-coding gene included. We have hypothesized that this positive effect of MtrY on mithramycin biosynthesis is the result of increasing expression of mtmR, either directly or indirectly. However, promoter-probe assays demonstrated that the activity of mtmRp was higher in the absence of MtrY (S. argillaceus DY pR-H versus S. argillaceus WT pR-H; Fig. 4a ) and was lower when MtrY was present (S. albus pR-Y versus S. albus pR-E; Fig. 6a ) at early incubation times, which suggests that MtrY could also be acting as a repressor of mtmRp activity, but was somehow required at later times to sustain its high activity. Curiously, addition of mithramycin to cultures of S. albus expressing mtrY (S. albus pR-Y) not only released the repression, but rather had the opposite effect, as mtmRp showed higher promoter activity in the presence of MtrY and mithramycin (pR-Y versus pR-E; Fig. 6b ). These results support the idea that MtrY plays a dual role on mtmRp depending on the conditions tested (i.e. acting as a repressor or positive regulator in the absence or presence of mithramycin, respectively). Although we cannot discard indirect regulatory effects of MtrY on still unknown regulatory signals, the hypothesis drawn here would explain results shown in this paper and would be in agreement with the fact that normal mithramycin yields depend on mtrY expression. A dual role has also been proposed for the TetR-like DnrO regulatory protein in the biosynthesis pathway of doxorubicin of Streptomyces peucetius. It was shown that this protein represses expression of its coding gene (this repression being released by the binding of glycosylated biosynthesis intermediates to DnrO) and that the modified protein triggers expression of the regulator dnrN that is essential for doxorubicin biosynthesis (Ajithkumar & Prasad, 2010; Jiang & Hutchinson, 2006; Otten et al., 2000) .
Based on the results in this paper, we propose a model for the regulation of mithramycin biosynthesis (Fig. 7) . According to this model, at early stages of growth mtrY would be transcribed from mtrYp, and the product MtrY would repress mtmRp and mtrYp promoters, keeping expression of mithramycin biosynthesis and resistance genes at a low level.
With increasing cell growth and in response to still unknown regulatory signals acting on mtmRp, transcription of mtmR would start. MtmR would activate expression of mithramycin biosynthesis genes by acting on at least seven promoters that control expression of one monocistronic and six polycistronic units, which code for all mithramycin biosynthesis enzymes (and resistance genes). This would lead to the beginning of mithramycin production. When the intracellular concentration of mithramycin (or some biosynthesis intermediates) increases, this would bind to MtrY releasing it from mtrYp and allowing stronger expression of resistance genes, and consequently avoiding self-suicide of the producer strain during the production period. In addition, MtrY combined with its ligand mithramycin would interact with mtmRp, enhancing its activity and so transcription of mtmR, which would lead to an increase of production levels of mithramycin at later times.
